imatinib mesylate has been researched along with Bowel Diseases, Inflammatory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, RH; Becker, C; Britzen-Laurent, N; Geppert, CI; Handtrack, C; Jeon, NL; Kersting, S; Kramer, V; Langer, V; Lee, S; Naschberger, E; Ramming, A; Rath, T; Regensburger, D; Schmid, B; Schumann, M; Skottke, L; Stürzl, M; Suchowski, K; Tripal, P; Vivi, E; Waldner, MJ; Winkler, TH; Wohlfahrt, T | 1 |
| De Backer, O; Lefebvre, RA | 1 |
1 trial(s) available for imatinib mesylate and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption.
Topics: Adherens Junctions; Adult; Aged; Animals; Antigens, CD; Cadherins; Endothelial Cells; Female; Humans; Imatinib Mesylate; Inflammatory Bowel Diseases; Interferon-gamma; Male; Mice; Mice, Knockout; Middle Aged | 2019 |
1 other study(ies) available for imatinib mesylate and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Is there a role for imatinib in inflammatory bowel disease?
Topics: Benzamides; Humans; Imatinib Mesylate; Inflammatory Bowel Diseases; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor Protein-Tyrosine Kinases | 2008 |